A Phase Ⅱ/Ⅲ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer

NCT07462143 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal (Colon or Rectal) Cancer

Interventions

DRUG: RC148 (Dose 1) plus Capecitabine and Oxaliplatin
DRUG: RC148 (Dose 2) plus Capecitabine and Oxaliplatin

Sponsor

RemeGen Co., Ltd.